RACHAEL SAPP: Open Payments
NPI 1730127044 · MADISON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$248 in 12 payments from 9 companies in 2025. Trend: 2023 $270 · 2024 $320 · 2025 $248
Food & beverage: $248
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $50 |
| PFIZER INC. | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
| Lilly USA, LLC | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| INOGEN, INC. | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
Products named: VRAYLAR, NURTEC ODT, LEQVIO, MOUNJARO, TRELEGY ELLIPTA, Auvelity, FARXIGA, INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH.
Industry payments across FL — which companies pay providers there.
